Concepedia

Publication | Open Access

Somatotroph Tumor Progression during Pegvisomant Therapy: A Clinical and Molecular Study

DOIFull Paper Access

61

Citations

42

References

2010

Year

Mónica Marazuela, Amalia-Elisa Paniagua, Manuel D. Gahete, T. Lucas, Cristina Álvarez‐Escolá, Rafael González Manzanares, José Cameselle‐Teijeiro, Manuel Luque‐Ramírez, Raúl M. Luque, Emilio Fernández Rodríguez,
The Journal of Clinical Endocrinology & Metabolism

Abstract

No previous radiotherapy, shorter duration of prepegvisomant somatostatin analog therapy, and higher tumor expression of GH and insulin receptor could be risk factors for tumor growth during pegvisomant therapy.

References

YearCitations

Page 1